Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study

INTRODUCTION: Usage patterns and effectiveness of a longer-acting formulation of insulin glargine at a strength of 300 units per milliliter (Gla-300) have not been studied in real-world clinical practice. This study evaluated differences in dosing and clinical outcomes before and after Gla-300 treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Shaloo, Wang, Hongwei, Skolnik, Neil, Tong, Liyue, Liebert, Ryan M., Lee, Lulu K., Stella, Peter, Cali, Anna, Preblick, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778176/
https://www.ncbi.nlm.nih.gov/pubmed/29313285
http://dx.doi.org/10.1007/s12325-017-0651-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778176/
https://www.ncbi.nlm.nih.gov/pubmed/29313285
http://dx.doi.org/10.1007/s12325-017-0651-3

Ejemplares similares